Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/05/2026 | Q4 | $128.5M | -- | -- | $0.47 | -- |
| 10/30/2025 | Q3 | $131.8M | $147.1M | $0.55 | $0.53 | $0.02 |
| 07/31/2025 | Q2 | $130.8M | $142M | $0.52 | $0.52 | -$0.00 |
| 05/01/2025 | Q1 | $134.6M | $145.5M | $0.52 | $0.52 | -$0.01 |
| 02/06/2025 | Q4 | $119.6M | $136.8M | $0.46 | $0.43 | $0.03 |
| 10/24/2024 | Q3 | $125.7M | $136.3M | $0.50 | $0.50 | $0.00 |
| 07/25/2024 | Q2 | $130.8M | $140.5M | $0.57 | $0.53 | $0.04 |
| 04/25/2024 | Q1 | $126M | $144.9M | $0.59 | $0.50 | $0.09 |
| 02/01/2024 | Q4 | $119.1M | $122.9M | $0.41 | $0.46 | -$0.06 |
| 10/26/2023 | Q3 | -- | $133.3M | $0.48 | -- | -- |
| 07/27/2023 | Q2 | -- | $140.2M | $0.50 | -- | -- |
| 04/27/2023 | Q1 | -- | $140.3M | $0.56 | -- | -- |
| 02/02/2023 | Q4 | -- | $127.4M | $0.44 | -- | -- |
| 10/27/2022 | Q3 | -- | $127.2M | $0.47 | -- | -- |
| 07/28/2022 | Q2 | -- | $130.3M | $0.49 | -- | -- |
| 04/28/2022 | Q1 | -- | $128.5M | $0.56 | -- | -- |
| 02/03/2022 | Q4 | -- | $113.5M | $0.38 | -- | -- |
| 10/28/2021 | Q3 | -- | $116.4M | $0.46 | -- | -- |
| 07/29/2021 | Q2 | -- | $119.9M | $0.48 | -- | -- |
| 04/29/2021 | Q1 | -- | $116.5M | $0.58 | -- | -- |
| 02/04/2021 | Q4 | -- | $103.2M | $0.41 | -- | -- |
| 10/29/2020 | Q3 | -- | $98.7M | $0.34 | -- | -- |
| 07/30/2020 | Q2 | -- | $92M | $0.31 | -- | -- |
| 04/30/2020 | Q1 | -- | $106M | $0.49 | -- | -- |
| 02/06/2020 | Q4 | -- | $110.1M | $0.36 | -- | -- |
| 10/17/2019 | Q3 | -- | $101.5M | $0.36 | -- | -- |
| 07/18/2019 | Q2 | -- | $106.5M | $0.39 | -- | -- |
| 04/18/2019 | Q1 | -- | $99M | $0.42 | -- | -- |
| 01/31/2019 | Q4 | -- | $92.1M | $0.30 | -- | -- |
| 10/18/2018 | Q3 | -- | $95.3M | $0.32 | -- | -- |
| 07/19/2018 | Q2 | -- | $95.6M | $0.34 | -- | -- |
| 04/19/2018 | Q1 | -- | $96.5M | $0.38 | -- | -- |
| 02/01/2018 | Q4 | -- | $88.3M | -$0.07 | -- | -- |
| 10/18/2017 | Q3 | -- | $87.6M | $0.27 | -- | -- |
| 07/18/2017 | Q2 | -- | $87.8M | $0.26 | -- | -- |
| 04/19/2017 | Q1 | -- | $84.1M | $0.31 | -- | -- |
| 02/01/2017 | Q4 | -- | $77M | $0.20 | -- | -- |
| 10/19/2016 | Q3 | -- | $77.6M | $0.21 | -- | -- |
| 07/19/2016 | Q2 | -- | $77.3M | $0.19 | -- | -- |
| 04/20/2016 | Q1 | -- | $83.2M | $0.28 | -- | -- |
| 02/03/2016 | Q4 | -- | $73.7M | $0.18 | -- | -- |
Exponent, Inc. reported $147.1M worth of top line sales in its most recent quarter.
Exponent, Inc. announced earnings per share of $0.55 which represents a beat of analyst forecast a $0.53 per share.
Exponent, Inc. reported $36.7M that represents $0.72 per share over the last quarter.
Exponent, Inc.'s earnings are forecast to decrease from $2.11 per share to $2.17 per share next year representing a decrease of -2.66%.
Exponent, Inc.'s next earnings date is February 5, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.